These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32921425)

  • 1. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
    Vecchierini MF; Kilic-Huck U; Quera-Salva MA;
    Rev Neurol (Paris); 2021 Mar; 177(3):245-259. PubMed ID: 32921425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS).
    Quera-Salva MA; Kilic-Huck U; Vecchierini MF;
    Rev Neurol (Paris); 2021 Mar; 177(3):235-244. PubMed ID: 33446328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sleep disorders in patients with a neurocognitive disorder].
    Moderie C; Carrier J; Dang-Vu TT
    Encephale; 2022 Jun; 48(3):325-334. PubMed ID: 34916075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG; Rigaud AS
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS).
    Geoffroy PA; Micoulaud Franchi JA; Lopez R; Schroder CM;
    Encephale; 2019 Nov; 45(5):413-423. PubMed ID: 31248601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders.
    Spiegelhalder K; Nissen C; Riemann D
    Handb Exp Pharmacol; 2019; 253():261-276. PubMed ID: 28707143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ; Sack RL; Lewy AJ
    Sleep; 1998; 21(1):52-68. PubMed ID: 9485533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
    Schröder CM; Broquère MA; Claustrat B; Delorme R; Franco P; Lecendreux M; Tordjman S
    Encephale; 2022 Jun; 48(3):294-303. PubMed ID: 35120753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
    Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
    Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA
    Drugs Aging; 2012 Nov; 29(11):911-23. PubMed ID: 23044640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of chronobiotics in the resynchronization of the sleep/wake cycle. Therapeutical application in the early phases of Alzheimer's disease.
    Cardinali DP; Furio AM; Brusco LI
    Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):80-90. PubMed ID: 22074583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as a Chronobiotic with Sleep-promoting Properties.
    Cruz-Sanabria F; Carmassi C; Bruno S; Bazzani A; Carli M; Scarselli M; Faraguna U
    Curr Neuropharmacol; 2023; 21(4):951-987. PubMed ID: 35176989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating chronobiological components of chronic insomnia.
    Lack LC; Wright HR
    Sleep Med; 2007 Sep; 8(6):637-44. PubMed ID: 17383935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of melatonin for the treatment of insomnia.
    Zisapel N
    Biol Signals Recept; 1999; 8(1-2):84-9. PubMed ID: 10085468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder.
    Byun JI; Shin YY; Seong YA; Yoon SM; Hwang KJ; Jung YJ; Cha KS; Jung KY; Shin WC
    Sleep Breath; 2023 Mar; 27(1):309-318. PubMed ID: 35141811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.